Vascular Biogen. Ord (VBLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VBLT | CMMB | GDTC | ||
| Company | Vascular Biogen. Ord | Chemomab Therapeutics Ltd ADR | Cytomed Therapeutics Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.1734 | 1.7299 | 0.9900 | ||
| High | 0.1925 | 1.7299 | 1.0100 | ||
| Low | 0.1526 | 1.6200 | 0.9800 | ||
| Latest | 0.1560 | 1.6200 | 1.0100 | ||
| Change | -0.0150 | -0.0700 | +0.0101 | ||
| % Change | -8.77% | -4.14% | +1.01% | ||
| Volume | 5,652,700 | 15,800 | 1,800 | ||
| 20-Day Average Volume | 1,006,195 | 33,115 | 5,905 | ||
| Previous Close | 0.1710 | 1.6900 | 0.9999 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2249 | 1.6335 | 1.0114 | ||
| 20-Day Raw Stochastic | 2.51% | 40.48% | 68.27% | ||
| 20-Day Relative Strength | 35.56 | 46.01 | 46.94 | ||
| Weighted Alpha | +1.00 | -68.21 | -62.53 | ||
| Today's Opinion | 40% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 24% Buy | 80% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -33.76% since 10/09/23 | -2.99% since 04/16/26 | -0.98% since 04/16/26 | ||
| Low | 0.1526 on 10/16/23 | 1.6200 on 04/23/26 | 0.9700 on 04/17/26 | ||
| High | 0.2880 on 10/12/23 | 1.7300 on 04/21/26 | 1.0200 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | -33.33% since 09/15/23 | -3.57% since 03/23/26 | -1.94% since 03/23/26 | ||
| Low | 0.1526 on 10/16/23 | 1.4500 on 03/27/26 | 0.9024 on 04/09/26 | ||
| High | 0.2880 on 10/12/23 | 1.8700 on 04/01/26 | 1.0600 on 04/06/26 | ||
| 3-Month | |||||
| %Chg | -46.99% since 07/14/23 | -3.57% since 01/23/26 | +1.00% since 01/23/26 | ||
| Low | 0.1526 on 10/16/23 | 1.3500 on 02/25/26 | 0.7282 on 01/27/26 | ||
| High | 0.3098 on 07/25/23 | 2.2359 on 03/17/26 | 1.2500 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | -20.93% since 04/14/23 | -44.33% since 10/23/25 | -58.44% since 10/23/25 | ||
| Low | 0.1520 on 04/25/23 | 1.3500 on 02/25/26 | 0.7282 on 01/27/26 | ||
| High | 0.3200 on 07/13/23 | 3.4399 on 10/27/25 | 3.1000 on 11/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,112 | 12,155 | 11,832 | ||
| Shares Outstanding, K | 77,640 | 7,192 | 11,833 | ||
| Annual Sales | 660,000 | 0 | 250,000 | ||
| Annual Net Income | -32,300,000 | -9,000,000 | -3,100,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -870,000 | -1,870,000 | N/A | ||
| 60-Month Beta | 0.76 | 0.58 | -0.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 08/14/23 | -0.24 on 03/19/26 | N/A | ||
| Latest Earnings Date | 11/13/23 | 05/21/26 | 06/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||